Cspc Zhongqi Pharmaceutical Technology Co., Ltd.

This phase 3 trial tests a new long-acting octreotide injection (SYHX2008) in 154 adults with active acromegaly, a condition where the body makes too much growth hormone. The main goal is to see if the drug can bring hormone levels back to normal. Participants will receive the in…

This Phase 1 study tests a single dose of SYH2082 injection in 44 healthy adults who are overweight or have obesity. The main goal is to check safety and side effects, not weight loss. Participants will receive either the drug or a placebo, and researchers will monitor how the dr…

This clinical trial is testing a new approach for people with advanced liver cancer whose first treatment stopped working. The study combines a targeted chemotherapy infusion (paclitaxel liposome) delivered directly into the liver artery with systemic drugs like immunotherapy and…

This phase III trial tests a vitamin B12 injection (hydroxocobalamin chloride) in 20 children aged 6 months to 18 years with a specific type of methylmalonic acidemia (cobalamin C deficiency). The goal is to see if the injection can normalize levels of certain acids in the blood …